← Back to Hypothesis | Reviews

⭐ GrimAge Acceleration as a Cell-Type-Resolved CSF Biomarker Panel for Early AD St

Composite Score: 0.369 | Target: CSF, DNA, MCI, GDF, PAI

Filter by type:

No structured reviews yet. Be the first to review this hypothesis!